Chaplin, W. J. http://orcid.org/0000-0002-2024-9685
Lewis, H. R. http://orcid.org/0000-0002-4103-8262
Shahtaheri, S. M. http://orcid.org/0000-0002-9623-878X
Millar, B. S. http://orcid.org/0000-0002-4535-4828
McWilliams, D. F. http://orcid.org/0000-0002-0581-1895
Gladman, J. R. F. http://orcid.org/0000-0002-8506-7786
Walsh, D. A. http://orcid.org/0000-0002-6316-5692
Funding for this research was provided by:
National Institute for Health and Care Research
Versus Arthritis (20777)
Article History
Received: 11 July 2023
Accepted: 14 December 2023
First Online: 15 February 2024
Declarations
:
: DMcW declares grant and research support from Pfizer Ltd, GlaxoSmithKline Plc and Lilly Ltd. DAW declares a personal financial interest in his employment by the University of Nottingham, who receive funding for his salary from the UK Government, Sherwood Forest Hospitals NHS Foundation Trust and UKRI. In the past 36 months, DAW declared the following non-personal financial interests: consultancy through his employment with the University of Nottingham to Pfizer Ltd, Eli Lilly, AbbVie Ltd, Galapagos and Reckitt Benckiser Health Ltd, and GlaxoSmithKline Plc, and responsibilities for investigator-led grants outside the work in this presentation held by the University of Nottingham from Pfizer Ltd and Lilly Ltd. The other authors do not have any competing interests.
: Ethical approval for the Investigating Musculoskeletal Health & Wellbeing study was by the Central London Research Ethics Committee (ref.18/LO/0870 IRAS 227758). Clinicaltrials.gov NCT03696134 registered 4/10/2018. The study was conducted according to the Declaration of Helsinki the principles of Good Clinical Practice (GCP) and the UK Policy Framework for Health and Social Care Research, 2018. Written informed consent was obtained from all participants prior to participation and they were all assured that they could withdraw their consent at any time without consequences.
: Not applicable.